• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性和原发性(AL)心脏淀粉样变性:超声心动图表现相似但临床结局截然不同的疾病。

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

作者信息

Dubrey S W, Cha K, Skinner M, LaValley M, Falk R H

机构信息

Section of Cardiology, Boston University School of Medicine, Massachusetts, USA.

出版信息

Heart. 1997 Jul;78(1):74-82. doi: 10.1136/hrt.78.1.74.

DOI:10.1136/hrt.78.1.74
PMID:9290406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC484868/
Abstract

OBJECTIVE

To determine whether patients with myocardial amyloidosis due either to AL (primary) amyloid or familial amyloid have distinguishing echocardiographic or electrocardiographic features; and to compare the prevalence of heart failure and survival in the two types of amyloidosis in relation to echocardiographic findings.

DESIGN

Blinded group comparison of randomly selected cases of cardiac amyloidosis.

SETTING

International referral centre for amyloid research and treatment.

PATIENTS

36 patients with cardiac amyloid heart disease, of whom 12 had familial and 24 had primary AL amyloidosis.

RESULTS

Familial and AL echocardiograms were morphologically indistinguishable, with similar left ventricular wall thickness, mean (SD) 15.4 (2.3) nu 15.8 (2.5) mm, respectively; right ventricular wall thickness was also similar between amyloid types: 9.6 (2.8) nu 9.7 (6.5) mm, respectively. Doppler indices of left and right ventricular function, left ventricular volume, and ejection fraction were also similar. Low voltage electrocardiograms (< 0.5 mV) were more common in the AL (16/24, 67%) than in the familial group (4/12, 25%), P < 0.05. The one year survival for familial and AL forms was 92% (11/12) nu 38% (6/24), respectively, with virtually all deaths due to cardiac causes.

CONCLUSIONS

Although cardiac involvement is echocardiographically indistinguishable, cardiac mortality is very different between the two forms of amyloidosis. Preservation of electrocardiographic voltage in familial amyloidosis suggests that the particular biochemical characteristics of distinct types of amyloid fibril have different pathological effects on the myocardium. This distinction becomes critical in the evaluation, treatment, and management of patients who have a diagnosis within the spectrum of the protein deposition diseases.

摘要

目的

确定由AL(原发性)淀粉样蛋白或家族性淀粉样蛋白引起的心肌淀粉样变性患者是否具有独特的超声心动图或心电图特征;并根据超声心动图结果比较两种类型淀粉样变性中心力衰竭的患病率和生存率。

设计

对随机选择的心脏淀粉样变性病例进行盲法分组比较。

地点

国际淀粉样变性研究与治疗转诊中心。

患者

36例心脏淀粉样变性心脏病患者,其中12例为家族性,24例为原发性AL淀粉样变性。

结果

家族性和AL型超声心动图在形态上无法区分,左心室壁厚度相似,分别为平均(标准差)15.4(2.3)毫米和15.8(2.5)毫米;淀粉样变性类型之间的右心室壁厚度也相似:分别为9.6(2.8)毫米和9.7(6.5)毫米。左、右心室功能、左心室容积和射血分数的多普勒指标也相似。低电压心电图(<0.5mV)在AL组(16/24,67%)比家族性组(4/12,25%)更常见,P<0.05。家族性和AL型的一年生存率分别为92%(11/12)和38%(6/24),几乎所有死亡均由心脏原因导致。

结论

尽管心脏受累在超声心动图上无法区分,但两种形式的淀粉样变性中心脏死亡率差异很大。家族性淀粉样变性中保留心电图电压表明,不同类型淀粉样纤维的特定生化特征对心肌有不同的病理影响。这种区别在对蛋白质沉积疾病范围内诊断的患者进行评估、治疗和管理时变得至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/f4fc06a13e15/heart00008-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/300b85b42fc1/heart00008-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/768232896875/heart00008-0099-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/f4fc06a13e15/heart00008-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/300b85b42fc1/heart00008-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/768232896875/heart00008-0099-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a36/484868/f4fc06a13e15/heart00008-0101-a.jpg

相似文献

1
Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.家族性和原发性(AL)心脏淀粉样变性:超声心动图表现相似但临床结局截然不同的疾病。
Heart. 1997 Jul;78(1):74-82. doi: 10.1136/hrt.78.1.74.
2
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.系统性心脏淀粉样变:3种主要类型的疾病特征与临床病程
Circulation. 2009 Sep 29;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334. Epub 2009 Sep 14.
3
Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.以心力衰竭为表现的老年系统性淀粉样变:与轻链相关性淀粉样变的比较。
Arch Intern Med. 2005 Jun 27;165(12):1425-9. doi: 10.1001/archinte.165.12.1425.
4
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.转甲状腺素相关与轻链心脏淀粉样变性的左心室结构和功能。
Circulation. 2014 May 6;129(18):1840-9. doi: 10.1161/CIRCULATIONAHA.113.006242. Epub 2014 Feb 21.
5
Abnormal stress echocardiography findings in cardiac amyloidosis.心脏淀粉样变性中异常的应力超声心动图表现。
Amyloid. 2016 Jun;23(2):124-31. doi: 10.1080/13506129.2016.1176020. Epub 2016 May 2.
6
Signal-averaged electrocardiography in patients with AL (primary) amyloidosis.AL(原发性)淀粉样变性患者的信号平均心电图
Am Heart J. 1997 Dec;134(6):994-1001. doi: 10.1016/s0002-8703(97)70017-6.
7
Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.心脏淀粉样变性的亚型特异性相互作用与预后
J Am Heart Assoc. 2016 Mar 24;5(3):e002877. doi: 10.1161/JAHA.115.002877.
8
Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.经心内膜心肌活检证实,临床和超声心动图特征对心脏淀粉样变性患者心脏事件发生的影响。
Int J Cardiol. 2014 Oct 20;176(3):753-9. doi: 10.1016/j.ijcard.2014.07.100. Epub 2014 Aug 2.
9
Prognostic significance of strain Doppler imaging in light-chain amyloidosis.应变多普勒成像在轻链淀粉样变性中的预后意义。
JACC Cardiovasc Imaging. 2010 Apr;3(4):333-42. doi: 10.1016/j.jcmg.2009.11.013.
10
Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.心脏淀粉样变性中舒张功能的多普勒测量的预后意义。一项多普勒超声心动图研究。
Circulation. 1991 Mar;83(3):808-16. doi: 10.1161/01.cir.83.3.808.

引用本文的文献

1
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis.走出黑暗。心脏淀粉样变性中的心脏性猝死。
Rev Cardiovasc Med. 2022 Oct 14;23(10):345. doi: 10.31083/j.rcm2310345. eCollection 2022 Oct.
2
Functions and Clinical Significance of Myocardial Cell-Derived Immunoglobulins.心肌细胞衍生免疫球蛋白的功能与临床意义。
Adv Exp Med Biol. 2024;1445:119-128. doi: 10.1007/978-981-97-0511-5_9.
3
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis.免疫球蛋白轻链淀粉样变性患者的不定潜能克隆性造血。

本文引用的文献

1
A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.一种特殊形式的周围神经病变;家族性非典型全身性淀粉样变性,周围神经有特殊受累情况。
Brain. 1952 Sep;75(3):408-27. doi: 10.1093/brain/75.3.408.
2
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.心脏淀粉样变性患者窦性心律时出现的心房血栓:心房电机械分离的证据。
Br Heart J. 1995 Nov;74(5):541-4. doi: 10.1136/hrt.74.5.541.
3
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.
Blood Adv. 2024 Jul 9;8(13):3427-3436. doi: 10.1182/bloodadvances.2024012840.
4
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment.心脏淀粉样变性:临床特征、发病机制、诊断和治疗。
Turk Patoloji Derg. 2024;40(1):1-9. doi: 10.5146/tjpath.2023.12923.
5
Amyloidosis of the Heart: A Comprehensive Review.心脏淀粉样变性:综述
Cureus. 2023 Feb 21;15(2):e35264. doi: 10.7759/cureus.35264. eCollection 2023 Feb.
6
New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.新的先进成像参数和生物标志物——转甲状腺素蛋白心肌病诊断与预后的新进展
J Clin Med. 2022 Apr 22;11(9):2360. doi: 10.3390/jcm11092360.
7
Clinical management of amyloid cardiomyopathy.淀粉样心肌病的临床管理。
Heart Fail Rev. 2022 Sep;27(5):1549-1557. doi: 10.1007/s10741-021-10159-w. Epub 2021 Sep 1.
8
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.甲状腺素运载蛋白:从结构稳定性到骨关节炎和心血管疾病。
Cells. 2021 Jul 13;10(7):1768. doi: 10.3390/cells10071768.
9
Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly.心脏淀粉样变性——老年人心力衰竭的一个诊断不足的病因。
J Saudi Heart Assoc. 2020 Apr 17;32(1):98-102. doi: 10.37616/2212-5043.1016. eCollection 2020.
10
First case of cardiac amyloidosis presenting as right atrial mass.首例表现为右心房肿块的心脏淀粉样变性病例。
Anatol J Cardiol. 2019 Sep;22(3):152-154. doi: 10.14744/AnatolJCardiol.2019.49683.
遗传性转甲状腺素蛋白淀粉样变性患者肝移植后的临床改善及淀粉样蛋白消退
Lancet. 1993 May 1;341(8853):1113-6. doi: 10.1016/0140-6736(93)93127-m.
4
The epidemiology of AL and AA amyloidosis.AL型和AA型淀粉样变性的流行病学
Baillieres Clin Rheumatol. 1994 Aug;8(3):627-34. doi: 10.1016/s0950-3579(05)80119-0.
5
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.原发性系统性淀粉样变性:474例患者的临床及实验室特征
Semin Hematol. 1995 Jan;32(1):45-59.
6
Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients.导致心脏功能障碍的心脏淀粉样变性:54例尸检患者分析
Am J Cardiol. 1983 Jul;52(1):137-46. doi: 10.1016/0002-9149(83)90084-x.
7
Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.淀粉样心肌病:通过独特的电压/质量关系进行表征。
Am J Cardiol. 1982 Jan;49(1):9-13. doi: 10.1016/0002-9149(82)90270-3.
8
Echocardiographic features in familial amyloidosis with polyneuropathy.伴有多神经病的家族性淀粉样变性的超声心动图特征。
Acta Med Scand. 1983;214(4):273-8. doi: 10.1111/j.0954-6820.1983.tb10634.x.
9
Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy.伴有多神经病的家族性淀粉样变性中的房室和心室内传导
Acta Med Scand. 1980;208(1-2):77-80. doi: 10.1111/j.0954-6820.1980.tb01155.x.
10
Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.心脏淀粉样变性的存在及严重程度的无创评估。一项通过横断面超声心动图和锝-99m焦磷酸盐闪烁扫描术对家族性淀粉样变性伴多神经病进行的研究。
Br Heart J. 1984 Sep;52(3):321-6. doi: 10.1136/hrt.52.3.321.